Search Results - "Silverman, Daniel H. S"

Refine Results
  1. 1

    Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia by Rasgon, Natalie L, Geist, Cheri L, Kenna, Heather A, Wroolie, Tonita E, Williams, Katherine E, Silverman, Daniel H S

    Published in PloS one (12-03-2014)
    “…The objective of this study was to examine the effects of estrogen-based hormone therapy (HT) on regional cerebral metabolism in postmenopausal women (mean age…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Neuroimaging Evidence of Cerebellar Involvement in Premenstrual Dysphoric Disorder by Rapkin, Andrea J, Berman, Steven M, Mandelkern, Mark A, Silverman, Daniel H.S, Morgan, Melinda, London, Edythe D

    Published in Biological psychiatry (1969) (15-02-2011)
    “…Background Premenstrual dysphoric disorder (PMDD) is a debilitating cyclic disorder that is characterized by affective symptoms, including irritability,…”
    Get full text
    Journal Article
  4. 4

    Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD by Silverman, Daniel H.S, Geist, Cheri L, Kenna, Heather A, Williams, Katherine, Wroolie, Tonita, Powers, Bevin, Brooks, John, Rasgon, Natalie L

    Published in Psychoneuroendocrinology (01-05-2011)
    “…Summary Differential cerebral metabolic effects of various hormone therapy formulations, and their associations with cognitive status, remain to be…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy by Rasgon, Natalie L, Kenna, Heather A, Wroolie, Tonita E, Williams, Katherine E, DeMuth, Bevin N, Silverman, Daniel H.S

    Published in Psychiatry research. Neuroimaging (30-07-2014)
    “…Abstract Insulin resistance (IR) is a putative risk factor for cognitive decline and dementia, and has been shown to impede neuronal glucose metabolism in…”
    Get full text
    Journal Article
  7. 7

    Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research by Saykin, Andrew J., de Ruiter, Michiel B., McDonald, Brenna C., Deprez, Sabine, Silverman, Daniel H. S.

    Published in Brain imaging and behavior (01-12-2013)
    “…Cognitive changes in patients undergoing treatment for non-central nervous system (CNS) cancers have been recognized for several decades, yet the underlying…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology by Hickman, L Brian, Stern, John M, Silverman, Daniel H S, Salamon, Noriko, Vossel, Keith

    Published in Frontiers in neurology (27-09-2023)
    “…Accumulating evidence suggests amyloid and tau-related neurodegeneration may play a role in development of late-onset epilepsy of unknown etiology (LOEU). In…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline by Torosyan, Nare, Mason, Kelsey, Dahlbom, Magnus, Silverman, Daniel H. S.

    “…Purpose The aim of this study was to examine the value of fluorodeoxyglucose (FDG) positron emission tomography (PET) in predicting subsequent rates of…”
    Get full text
    Journal Article
  12. 12

    Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain Injury by Alcantara, April, Berenji, Gholam R., Scherling, Carole S., Durcanova, Beata, Diaz-Aguilar, Daniel, Silverman, Daniel H.S.

    Published in Journal of Nuclear Medicine (01-12-2019)
    “…Neuronuclear imaging has been used for several decades in the study of primary neurodegenerative conditions, such as dementia and parkinsonian syndromes, both…”
    Get full text
    Journal Article
  13. 13

    Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma by Wiseman, Gregory A., Leigh, Bryan, Erwin, William D., Lamonica, Dominick, Kornmehl, Ellen, Spies, Stewart M., Silverman, Daniel H. S., Witzig, Thomas E., Sparks, Richard B., White, Christine A.

    Published in Cancer (15-02-2002)
    “…BACKGROUND Zevalin consists of a murine anti‐CD20 monoclonal antibody (ibritumomab) conjugated to the linker‐chelator tiuxetan, which securely chelates…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Brain Metabolism During A Lower Extremity Voluntary Movement Task in Children With Spastic Cerebral Palsy by Fowler, Eileen G, Oppenheim, William L, Greenberg, Marcia B, Staudt, Loretta A, Joshi, Shantanu H, Silverman, Daniel H S

    Published in Frontiers in human neuroscience (25-05-2020)
    “…Reduced selective voluntary motor control (SVMC) is a primary impairment due to corticospinal tract (CST) injury in spastic cerebral palsy (CP). There are few…”
    Get full text
    Journal Article
  15. 15

    Radiation Dose Estimates for [18F]5-Fluorouracil Derived from PET-Based and Tissue-Based Methods in Rats by Kesner, Adam L., Hsueh, Wei-Ann, Czernin, Johannes, Padgett, Henry, Phelps, Michael E., Silverman, Daniel H. S.

    Published in Molecular imaging and biology (01-11-2008)
    “…Introduction Radiation dosimetry assessment often begins with measuring pharmaceutical biodistribution in rodents. The traditional approach to dosimetry in…”
    Get full text
    Journal Article
  16. 16

    Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy by Pio, Betty S, Park, Cecilia K, Pietras, Richard, Hsueh, Wei-Ann, Satyamurthy, Nagichettiar, Pegram, Mark D, Czernin, Johannes, Phelps, Michael E, Silverman, Daniel H S

    Published in Molecular imaging and biology (01-01-2006)
    “…The usefulness of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG)-positron emission tomography (PET) in monitoring breast cancer response to chemotherapy has previously…”
    Get full text
    Journal Article
  17. 17

    Neuroimaging and EEG-based explorations of cerebral substrates for suprapentasensory perception: A critical appraisal of recent experimental literature by Le, Christine, Silverman, Daniel H.S

    Published in Psychiatry research. Neuroimaging (30-11-2011)
    “…Abstract Many people have reported experiencing on at least one occasion what are often labeled "paranormal phenomena," and some people report having such…”
    Get full text
    Journal Article
  18. 18

    Advances in Evaluation of Primary Brain Tumors by Chen, Wei, MD, PhD, Silverman, Daniel H.S., MD, PhD

    Published in Seminars in nuclear medicine (01-07-2008)
    “…The evaluation of primary brain tumor is challenging. Neuroimaging plays a significant role. At diagnosis, imaging is needed to establish a differential…”
    Get full text
    Journal Article
  19. 19

    Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy by SCHWARZENBERG, Johannes, CZERNIN, Johannes, WEI CHEN, CLOUGHESY, Timothy F, ELLINGSON, Benjamin M, POPE, Whitney B, GROGAN, Tristan, ELASHOFF, David, GEIST, Cheri, SILVERMAN, Daniel H. S, PHELPS, Michael E

    Published in Clinical cancer research (01-07-2014)
    “…This study compares the value of 3,4-dihydroxy-6-[(18)F]-fluoro-l-phenylalanine ((18)F-FDOPA) positron emission tomography (PET) and MRI in assessing outcome…”
    Get full text
    Journal Article
  20. 20

    International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients by Deprez, Sabine, Kesler, Shelli R, Saykin, Andrew J, Silverman, Daniel H S, de Ruiter, Michiel B, McDonald, Brenna C

    “…Cancer- and treatment-related cognitive changes have been a focus of increasing research since the early 1980s, with meta-analyses demonstrating poorer…”
    Get full text
    Journal Article